Omar Abudayyeh, PhD

Brigham and Women’s Hospital; Harvard Medical School; Harvard University

Dr. Omar Abudayyeh Awarded Michelson Prize for Proposal to Develop RNA Therapies Against Diseases

The Michelson Medical Research Foundation and the Human Immunome Project have awarded one of the 2024 Michelson Prizes: Next Generation Grants to Dr. Omar Abudayyeh in recognition of his proposal, “Development of Programmable RNA Sensors for Next-Generation Cancer Immunotherapies,” to develop RNA editing tools that protect against cancer and other diseases.

About

Dr. Omar Abudayyeh is an assistant professor at Harvard Medical School, investigator at Brigham and Women’s Hospital and Mass General Brigham’s Gene and Cell Therapy Institute, and faculty member with the Department of Stem Cell and Regenerative Biology at Harvard University. His proposal, “Development of Programmable RNA Sensors for Next-Generation Cancer Immunotherapies,” will leverage mRNA therapies and cell state targeting technologies (RADARS) to achieve mRNA tumor-specific therapies. RADARS enables the targeted expression of genetic payloads based on transcriptional state of tumor cells, reducing the risks of side effects and enhancing treatment efficacy with the potential to revolutionize cancer immunotherapy.